Dementia Big
Researchers from the Indiana University Center for Aging Research and the Regenstrief Institute have performed the first study conducted in the United States under real-world conditions comparing patient adherence and tolerability to a class of drugs known as cholinesterase inhibitors. Although there are no known cures for Alzheimer’s disease or other dementias, drugs in this class may delay or slow the progression of symptoms in some individuals.
http://ift.tt/2o1HEyt
No comments:
Post a Comment